Company Overview - Qinhuangdao Huisianpu Medical Systems Inc.
6YRSQinhuangdao Huisianpu Medical Systems Inc.

Panoramica aziendale

Album aziendale3

Informazioni di base
Founded in 2011, Qinhuangdao Huisianpu Medical Systems Inc. is recognized as a hi-tech enterprise engaged in design,R&D,manufacture and sale of medical instruments and systems in biomedical field.Through the efforts in the past years,we have developed a team of over 50 professional R&D talents who are with the educational background of master or doctor degree and maintained long-term stable partnerships with multiple biomedical research institutes,colleges,universities and hospitals of Grade 3 Class A or above level.In addition,there are EMI and ESD academician workstation,biomedical research center and biomedical experience center,postdoctoral working station and provincial corporate R&D center. Over the years, HRA focus on disease screening and early detection, makes the history of utilizing biomedical technology into clinical and physical examination. HRA inherits the prevention health care concept in Traditional Chinese Medicine(TCM), adopts High-tech detection technology based on international standard,assesses and screens early-stage disease ,as well as intervenes and rehabilitates chronic diseases,provides continuous, integrated examination and rehabilitation services for each client. Shouldering the mission of National Health Management, HRA makes operational,targeted prevention and caring measures, accordingly, to reduce or even avoid the risk of disease, improves the quality of life for the people.
3.0/5
Accettabile
2 Reviews
  • 20 Le operazioni di
    30,000+
  • Tempo di risposta
    ≤13h
  • Tasso di risposta
    75.29%

Capacità di prodotto

Informazioni di fabbrica

Dimensione della fabbrica
10,000-30,000 square meters
Posizione della fabbrica
No. 9, Tianmahu Road, Longhai Road, Qinhuangdao City, Hebei Province, China
N. di linee di produzione
3
Contratto d'opera
OEM Service Offered
Valore della produzione annua
US$50 Million - US$100 Million